Xuan Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xuan Li has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- James G. Krueger
Laboratory for Investigative Dermatology The Rockefeller University New York New York USA
10 shared publications - Sandra Garcet
Laboratory of Investigative Dermatology The Rockefeller University New York New York USA
10 shared publications - Shunsuke Miura
Laboratory of Investigative Dermatology, The Rockefeller University, New York, New York, USA
6 shared publications - Darshna Rambhia
Laboratory for Investigative Dermatology, the Rockefeller University, New York, New York, USA
5 shared publications - Juana Gonzalez
Laboratory of Investigative Dermatology The Rockefeller University New York New York USA
5 shared publications - Kazuhiko Yamamura
Department of Dermatology Graduate School of Medical Sciences, Kyushu University Fukuoka Japan
5 shared publications
Latest Publications
The OX40 / OX40L Axis Promotes Th2 Activity and Impairs Regulatory T Cell Function in Atopic Dermatitis
Background: Clinical trials using monoclonal antibodies targeting the OX40/OX40L axis (AMG451, GBR830, KHK4083, and KY1005) have shown promise in long‐term disease modification of atopic dermatitis (AD). OX40/OX40L enhances survival of effector T cells and inhibits regulatory T cells (Tregs) function in other inflammatory diseases, but its mechanism of action in AD is unelucidated. We aimed to evaluate OX40‐ and OX40L‐expressing cells in the skin and blood of AD patients to understand how the axis promotes T cell activity and inflammation. Methods: Skin samples from AD and healthy controls (HCs) were evaluated using immunohistochemistry (IHC) and immunofluorescence (IF). Flow cytometry was used to analyze peripheral blood mononuclear cells (PBMCs), and RT‐qPCR and ELISA were performed on purified effector CD4 + T cells and from AD patients and HCs. RNA‐seq analysis was conducted on effector CD4 + T cells and Tregs stimulated with anti‐CD3/28, with and without OX40L, in both AD patients and HCs. Results: IHC showed increased OX40 + and OX40L + cell expression in AD skin lesions. Circulating CLA + CD4 + T cells and CLA + Tregs upregulate OX40 expression in AD patients compared to HCs. OX40 + CLA + CD4 + Tregs correlated with SCORAD. RNA‐seq, RT‐qPCR, and ELISA revealed that the OX40/OX40L axis maintained the Th2 phenotype of effector CD4+ T cells and decreased IL‐10 produced by Tregs. Conclusion: AD patients exhibit significant upregulation of OX40 expression in effector and regulatory CD4 + T cells. Both subsets interact with OX40L‐expressing cells in the skin, leading to the promotion of skin inflammation by downregulation of function and anti‐inflammatory capacity of Tregs.
The OX40 / OX40L Axis Promotes Th2 Activity and Impairs Regulatory T Cell Function in Atopic Dermatitis
Background: Clinical trials using monoclonal antibodies targeting the OX40/OX40L axis (AMG451, GBR830, KHK4083, and KY1005) have shown promise in long‐term disease modification of atopic dermatitis (AD). OX40/OX40L enhances survival of effector T cells and inhibits regulatory T cells (Tregs) function in other inflammatory diseases, but its mechanism of action in AD is unelucidated. We aimed to evaluate OX40‐ and OX40L‐expressing cells in the skin and blood of AD patients to understand how the axis promotes T cell activity and inflammation. Methods: Skin samples from AD and healthy controls (HCs) were evaluated using immunohistochemistry (IHC) and immunofluorescence (IF). Flow cytometry was used to analyze peripheral blood mononuclear cells (PBMCs), and RT‐qPCR and ELISA were performed on purified effector CD4 + T cells and from AD patients and HCs. RNA‐seq analysis was conducted on effector CD4 + T cells and Tregs stimulated with anti‐CD3/28, with and without OX40L, in both AD patients and HCs. Results: IHC showed increased OX40 + and OX40L + cell expression in AD skin lesions. Circulating CLA + CD4 + T cells and CLA + Tregs upregulate OX40 expression in AD patients compared to HCs. OX40 + CLA + CD4 + Tregs correlated with SCORAD. RNA‐seq, RT‐qPCR, and ELISA revealed that the OX40/OX40L axis maintained the Th2 phenotype of effector CD4+ T cells and decreased IL‐10 produced by Tregs. Conclusion: AD patients exhibit significant upregulation of OX40 expression in effector and regulatory CD4 + T cells. Both subsets interact with OX40L‐expressing cells in the skin, leading to the promotion of skin inflammation by downregulation of function and anti‐inflammatory capacity of Tregs.
- Open Access
- 11 December 2025
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 146 (5) , 1399-1403.e11
Molecular, histological, and clinical effects of selective TYK2 inhibition with zasocitinib (TAK-279) in patients with moderate-to-severe plaque psoriasis
- 11 December 2025
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 146 (5) , 1399-1403.e11
Open AccessMolecular, histological, and clinical effects of selective TYK2 inhibition with zasocitinib (TAK-279) in patients with moderate-to-severe plaque psoriasis
- 20 July 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (3) , 536-547.e7
Hepatocyte Growth Factor Has Unique Functions in Keratinocytes that Differ from those of IL-17A and TNF and May Contribute to Inflammatory Pathways in Hidradenitis Suppurativa
- 20 July 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (3) , 536-547.e7
Hepatocyte Growth Factor Has Unique Functions in Keratinocytes that Differ from those of IL-17A and TNF and May Contribute to Inflammatory Pathways in Hidradenitis Suppurativa
- 6 March 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (8) , 1613-1617.e5
Staphylococcus Aureus and Streptococcus Pyogenes Induce Psoriasis-Related Transcriptomes Augmented by IL-17A and TNF-α
- 6 March 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (8) , 1613-1617.e5
Staphylococcus Aureus and Streptococcus Pyogenes Induce Psoriasis-Related Transcriptomes Augmented by IL-17A and TNF-α
- 7 December 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (5) , 832-841.e4
Cathelicidin Antimicrobial Peptide LL37 Induces Toll-Like Receptor 8 and Amplifies IL-36γ and IL-17C in Human Keratinocytes
- 7 December 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (5) , 832-841.e4
Cathelicidin Antimicrobial Peptide LL37 Induces Toll-Like Receptor 8 and Amplifies IL-36γ and IL-17C in Human Keratinocytes
- 1 August 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (8) , 2086-2090
IL-36 and IL-17A Cooperatively Induce a Psoriasis-Like Gene Expression Response in Human Keratinocytes
- 1 August 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (8) , 2086-2090
IL-36 and IL-17A Cooperatively Induce a Psoriasis-Like Gene Expression Response in Human Keratinocytes
- Open Access
- 1 April 2021
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 185 (3) , 585-594
Signalling of multiple interleukin (IL)‐17 family cytokines via IL‐17 receptor A drives psoriasis‐related inflammatory pathways
Background The IL‐23/IL‐17 immune axis is of central importance in psoriasis. However, the impact of IL‐17 family cytokines other than IL‐17A in psoriasis has not been fully established. Objectives To elucidate the contribution of IL‐17 family cytokines in psoriasis, we performed a comprehensive and systematic analysis of their expression, localization and functional activity. Methods To address the expression and localization of IL‐17 family cytokines, lesional and non‐lesional skin samples from psoriasis patients were analyzed by several complementary methods, including qPCR, immunoassays, in situ hybridization, and immunohistochemistry. Mechanistic studies assessing functional activity of IL‐17 family cytokines were performed using ex vivo cultured human skin biopsies and primary human keratinocytes. Results We demonstrate that IL‐17A, IL‐17F, IL‐17AF and IL‐17C are expressed at increased levels in psoriasis lesional skin and induce overlapping gene expression responses in ex vivo cultured human skin that correlate with the transcriptomic signature of psoriasis skin. Furthermore, we show that brodalumab, in contrast to ixekizumab, normalizes gene expression responses induced by the combination of IL‐17A, IL‐17F, IL‐17AF and IL‐17C in human keratinocytes. Conclusions Several IL‐17 ligands signaling through IL‐17RA are over‐expressed in psoriasis skin and induce similar psoriasis‐related inflammatory pathways demonstrating their relevance in relation to therapeutic intervention in psoriasis.
- 1 April 2021
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 185 (3) , 585-594
Open AccessSignalling of multiple interleukin (IL)‐17 family cytokines via IL‐17 receptor A drives psoriasis‐related inflammatory pathways
Background The IL‐23/IL‐17 immune axis is of central importance in psoriasis. However, the impact of IL‐17 family cytokines other than IL‐17A in psoriasis has not been fully established. Objectives To elucidate the contribution of IL‐17 family cytokines in psoriasis, we performed a comprehensive and systematic analysis of their expression, localization and functional activity. Methods To address the expression and localization of IL‐17 family cytokines, lesional and non‐lesional skin samples from psoriasis patients were analyzed by several complementary methods, including qPCR, immunoassays, in situ hybridization, and immunohistochemistry. Mechanistic studies assessing functional activity of IL‐17 family cytokines were performed using ex vivo cultured human skin biopsies and primary human keratinocytes. Results We demonstrate that IL‐17A, IL‐17F, IL‐17AF and IL‐17C are expressed at increased levels in psoriasis lesional skin and induce overlapping gene expression responses in ex vivo cultured human skin that correlate with the transcriptomic signature of psoriasis skin. Furthermore, we show that brodalumab, in contrast to ixekizumab, normalizes gene expression responses induced by the combination of IL‐17A, IL‐17F, IL‐17AF and IL‐17C in human keratinocytes. Conclusions Several IL‐17 ligands signaling through IL‐17RA are over‐expressed in psoriasis skin and induce similar psoriasis‐related inflammatory pathways demonstrating their relevance in relation to therapeutic intervention in psoriasis.
- 1 August 2020
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 140 (8) , 1546-1555.e4
Molecular and Cellular Responses to the TYK2/JAK1 Inhibitor PF-06700841 Reveal Reduction of Skin Inflammation in Plaque Psoriasis
- 1 August 2020
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 140 (8) , 1546-1555.e4
Molecular and Cellular Responses to the TYK2/JAK1 Inhibitor PF-06700841 Reveal Reduction of Skin Inflammation in Plaque Psoriasis
- 1 May 2020
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 140 (5) , 1015-1025.e4
Persistence of Inflammatory Phenotype in Residual Psoriatic Plaques in Patients on Effective Biologic Therapy
- 1 May 2020
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 140 (5) , 1015-1025.e4
Persistence of Inflammatory Phenotype in Residual Psoriatic Plaques in Patients on Effective Biologic Therapy